Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.48 |
| ▸ | PGR | P06401 | 2/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30761898 | 1.00 | AHR (0.48) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL4552248 | 1.00 | AHR (0.48) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL20927617 | 0.94 | AHR (0.44) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL16745229 | 0.91 | AHR (0.49) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL31135763 | 0.91 | AHR (0.49) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL22920775 | 0.87 | AHR (0.43) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL21102601 | 0.86 | ALOX5 (0.46) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL12594456 | 0.86 | PGR (0.50) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL17736183 | 0.86 | PGR (0.45) | AHRPGRALOX5MEN1KMT2A | |
| SCHEMBL16864452 | 0.85 | PGR (0.41) | AHRPGRALOX5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12490652-B2 | Organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2025-12-02 | — | — | US | disclosed |
| CN-114464744-B | Composition for organic photoelectric device, organic photoelectric device and display device | 三星SDI株式会社 | 2024-10-29 | — | — | CN | disclosed |
| CN-111162185-B | Organic photoelectric device and display device | 三星SDI株式会社 | 2022-12-23 | — | — | CN | disclosed |
| US-20220149295-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2022-05-12 | — | — | US | disclosed |
| CN-114464744-A | Composition for organic photoelectric device, and display device | 三星SDI株式会社 | 2022-05-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220149295-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD2, OR10J3, OCIAD1 | AHR 2176/4885PGR 3560/4885ALOX5 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.